Cybin (HELP) Depreciation & Amortization - Total (2022)
Cybin (HELP) posted Depreciation & Amortization - Total of $4474.0 for Q2 2022.
Cybin (HELP) Depreciation & Amortization - Total (2022) Analysis & Trends
Cybin's Depreciation & Amortization - Total history runs 1 years deep, the most recent figure standing at $4474.0 for Q2 2022.
- Quarterly Depreciation & Amortization - Total changed N/A year-over-year to $4474.0 in Q2 2022, while the trailing twelve-month figure through Feb 2023 was $4474.0 (changed N/A YoY) and the FY2023 annual result came in at $36915.1, changed N/A from the prior year.
- Depreciation & Amortization - Total was $4474.0 for Q2 2022 at Cybin.
- Across five years, Depreciation & Amortization - Total topped out at $4474.0 in Q2 2022 and bottomed at $4474.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Cybin | 262.76 Mn | 262.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2022 | 4,474.02 |